Swiss National Bank Boosts Stock Position in Kymera Therapeutics, Inc. (NASDAQ:KYMR)
Swiss National Bank raised its position in shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) by 15.6% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 76,200 shares of the company’s stock after buying an additional 10,300 shares during the quarter. Swiss National Bank’s […]
Swiss National Bank raised its position in shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) by 15.6% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 76,200 shares of the company’s stock after buying an additional 10,300 shares during the quarter. Swiss National Bank’s […]
